$SLTN jumps over 30% after Starling wins exclusivity with a major California partner adding ~230K capitated lives and setting up capitated revenue to double to ~$300M next year at ~30% gross margins. That expansion should drive 40%+ gross profit growth in 2027 while Specialty Pharmacy grows 58% with improving margins giving Starling two major earnings growth engines.
在 X 查看 ↗